---
figid: PMC5283709__MIRT-26-102-g1
figlink: ''
number: F1
caption: . MAPK/ERK pathway *This pathway begins with a mitogenic stimulus binding
  to a receptor tyrosine kinase, activating it. This triggers a cascade of protein
  activation, beginning with RAS and culminating with ERK. Once ERK is phosphorylated,
  it enters the nucleus and influences transcription, increasing expression of tumor-promoting
  genes and decreasing expression of tumor-suppressing genes. MAPK signaling can also
  be stimulated by genetic alterations in proteins RET and NTRK.
pmcid: PMC5283709
papertitle: A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq
  v.2.
reftext: Jorge Alsina, et al. Mol Imaging Radionucl Ther. 2017 Feb;26(Suppl 1):102-117.
pmc_ranked_result_index: '19178'
pathway_score: 0.92948
filename: MIRT-26-102-g1.jpg
figtitle: A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq
  v.2.
year: '2017'
organisms:
- Homo sapiens
ndex: 661c57a1-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5283709__MIRT-26-102-g1.html
  '@type': Dataset
  description: . MAPK/ERK pathway *This pathway begins with a mitogenic stimulus binding
    to a receptor tyrosine kinase, activating it. This triggers a cascade of protein
    activation, beginning with RAS and culminating with ERK. Once ERK is phosphorylated,
    it enters the nucleus and influences transcription, increasing expression of tumor-promoting
    genes and decreasing expression of tumor-suppressing genes. MAPK signaling can
    also be stimulated by genetic alterations in proteins RET and NTRK.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RET
  - MAPK3
  - MAP2K1
  - MAPK1
  - NTRK3
  - EIF2AK3
  - HRAS
  - NRAS
  - MAP2K2
  - NTRK2
  - NTRK1
  - KRAS
  - SLC5A5
  - MET
  - Cancer
  - Lung cancer
genes:
- word: RET,
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NTRK
  symbol: NTRK
  source: bioentities_symbol
  hgnc_symbol: NTRK3
  entrez: '4916'
- word: P-ERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: NTRK
  symbol: NTRK
  source: bioentities_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: NTRK
  symbol: NTRK
  source: bioentities_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NIS,
  symbol: NIS
  source: hgnc_alias_symbol
  hgnc_symbol: SLC5A5
  entrez: '6528'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC5283709__F1
redirect_from: /figures/PMC5283709__F1
figtype: Figure
---
